array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(87) "Acute Intermittent Porphyria Market Changes in 2024: Strategies for Survival and Growth"
["snippet_en"]=>
string(87) "Acute Intermittent Porphyria Market Changes in 2024: Strategies for Survival and Growth"
["url"]=>
string(145) "https://industrytoday.co.uk/market-research-industry-today/acute-intermittent-porphyria-market-changes-in-2024-strategies-for-survival-and-growth"
["image_url"]=>
NULL
["source"]=>
string(19) "industrytoday.co.uk"
["publication_date"]=>
string(10) "2024-04-15"
["categories"]=>
array(1) {
[0]=>
string(15) "Market Movement"
}
}
[1]=>
array(7) {
["title_en"]=>
string(116) "Laboratory Equipment and Disposables Market Price Trends Analysis Agilent Technologies, Bio-Rad Laboratories, Bruker"
["snippet_en"]=>
string(125) "Laboratory Equipment and Disposables Market Price Trends Analysis Agilent Technologies, Bio-Rad Laboratories, Bruker - Amoré"
["url"]=>
string(139) "http://amore.ng/news/47/laboratory-equipment-and-disposables-market-price-trends-analysis-agilent-technologies-bio-rad-laboratories-bruker/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/eb91a7f5-4a64-45ab-95c4-11ba821d36f3"
["source"]=>
string(8) "amore.ng"
["publication_date"]=>
string(10) "2024-04-02"
["categories"]=>
array(2) {
[0]=>
string(15) "Market Movement"
[1]=>
string(11) "Competition"
}
}
[2]=>
array(7) {
["title_en"]=>
string(118) "[Key Companies] Serological Transplant Diagnostics Market Bio-Rad Laboratories, Immucor, Siemens Healthineers - Amoré"
["snippet_en"]=>
string(118) "[Key Companies] Serological Transplant Diagnostics Market Bio-Rad Laboratories, Immucor, Siemens Healthineers - Amoré"
["url"]=>
string(136) "https://amore.ng/worldwide/28/key-companies-serological-transplant-diagnostics-market-bio-rad-laboratories-immucor-siemens-healthineers/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/267e4ebf-d554-4f9a-adc4-0851afa75478"
["source"]=>
string(8) "amore.ng"
["publication_date"]=>
string(10) "2024-03-14"
["categories"]=>
array(2) {
[0]=>
string(15) "Market Movement"
[1]=>
string(11) "Competition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(73) "Scope Fluidics (WSE:SCP) - Stock Price, News & Analysis - Simply Wall St"
["snippet_en"]=>
string(155) "Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more."
["url"]=>
string(72) "https://simplywall.st/stocks/pl/healthcare/wse-scp/scope-fluidics-shares"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6d70ed64-378e-46e9-bb90-37dead2c5896"
["source"]=>
string(13) "simplywall.st"
["publication_date"]=>
string(10) "2024-02-26"
["categories"]=>
array(5) {
[0]=>
string(15) "Market Movement"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(18) "General Investment"
[3]=>
string(9) "Valuation"
[4]=>
string(12) "Stock Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(118) "Epigenetics Market Growth 2024: Expanding Understanding of Gene Regulation | Merck Millipore Ltd, Bio-Rad Laboratories"
["snippet_en"]=>
string(143) "Epigenetics is the structural changes in chromosomal regions, which signal or perpetuate alteration in gene expression by turning it on or off."
["url"]=>
string(156) "https://www.einnews.com/pr_news/684860615/epigenetics-market-growth-2024-expanding-understanding-of-gene-regulation-merck-millipore-ltd-bio-rad-laboratories"
["image_url"]=>
NULL
["source"]=>
string(11) "einnews.com"
["publication_date"]=>
string(10) "2024-01-30"
["categories"]=>
array(2) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(15) "Market Movement"
}
}
[5]=>
array(7) {
["title_en"]=>
string(80) "Bio-Rad Laboratories (NYSE:BIO) - Stock Price, News & Analysis - Simply Wall St"
["snippet_en"]=>
string(162) "Research Bio-Rad Laboratories' (NYSE:BIO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more."
["url"]=>
string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8141cc14-f185-4b4b-8269-b0c9b83caef8"
["source"]=>
string(13) "simplywall.st"
["publication_date"]=>
string(10) "2024-01-24"
["categories"]=>
array(5) {
[0]=>
string(15) "Market Movement"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(10) "Executives"
[3]=>
string(12) "Board Change"
[4]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(99) "Future of Global Sensors in Healthcare Market During Geopolitical Unrest and Inflation 2023 to 2029"
["snippet_en"]=>
string(99) "Future of Global Sensors in Healthcare Market During Geopolitical Unrest and Inflation 2023 to 2029"
["url"]=>
string(158) "https://industrytoday.co.uk/market-research-industry-today/future-of-global-sensors-in-healthcare-market-during-geopolitical-unrest-and-inflation-2023-to-2029"
["image_url"]=>
NULL
["source"]=>
string(19) "industrytoday.co.uk"
["publication_date"]=>
string(10) "2023-12-18"
["categories"]=>
array(2) {
[0]=>
string(15) "Market Movement"
[1]=>
string(19) "Economic Conditions"
}
}
[7]=>
array(7) {
["title_en"]=>
string(120) "Venous Blood Collection Devices Market to Witness Outstanding Growth by 2030 | Sarstedt, Qiagen NV, Bio-Rad Laboratories"
["snippet_en"]=>
string(100) "The latest report titled ‘Venous Blood Collection Devices Market’ Global Industry Trends, Share,"
["url"]=>
string(174) "https://ekz-crosstour.ch/news/der-markt-fuer-venoese-blutentnahmegeraete-wird-bis-2030-ein-herausragendes-wachstum-verzeichnen-sarstedt-qiagen-nv-bio-rad-laboratories/484463/"
["image_url"]=>
NULL
["source"]=>
string(16) "ekz-crosstour.ch"
["publication_date"]=>
string(10) "2023-12-03"
["categories"]=>
array(2) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(15) "Market Movement"
}
}
[8]=>
array(7) {
["title_en"]=>
string(74) "Implied Volatility Surging for On Bio-Rad Laboratories (BIO) Stock Options"
["snippet_en"]=>
string(230) "Investors in Bio-Rad Laboratories, Inc. BIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2023 $240.00 Call had some of the highest implied volatility of all equi"
["url"]=>
string(104) "https://www.nasdaq.com/articles/implied-volatility-surging-for-on-bio-rad-laboratories-bio-stock-options"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-11-20"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Market Movement"
[2]=>
string(9) "Investors"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Research Bio-Rad Laboratories' (NYSE:BIO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Investors in Bio-Rad Laboratories, Inc. BIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2023 $240.00 Call had some of the highest implied volatility of all equi
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.